Boston CEO to Feature Governor Charlie Baker and 250 CEOs and Industry Leaders on May 26th and 27th

Share Article

Join Governor Charlie Baker and industry leaders from Alnylam, Biogen, Celgene, Flex, FORUM, Genzyme, GlaxoSmithKline, Ironwood, Johnson & Johnson, Merck, OvaScience, Pfizer, Sanofi and Shire for a 2-day, high-level, high-energy networking conference

Leading CEOs from the New York and Boston biotechnology communities will gather at Boston CEO on May 26th and 27th at The Four Seasons Hotel, Boston.

Boston CEO is a networking forum for industry CEOs and executives in the life sciences, offering exclusive access to key decision makers who influence deal making and investment. Attendees gain insights from presentations and panels featuring CEOs from several of the world's leading biopharmaceutical companies. Select healthcare investors also attend. Panel topics include What Constitutes Value and How to Price It, How Does Big Pharma Access Early-Stage Innovation?, Is the Rare Disease Model Sustainable?, Pharma Growth in Kendall Square: Pros and Cons, Genetic Therapies: The Promise and the Challenge, a Fireside Chat with former Sanofi CEO, Chris Viehbacher and many more.

"The Boston CEO conference is an invaluable opportunity for CEOs to gather in a casual and off-the-record atmosphere and discuss the most pressing issue in the biotech space and beyond”, says John Maraganore, CEO of Cambridge-based Alnylam.”I look forward to these conferences and fully support their mission to continue to grow Boston’s thriving biopharma community."

Robert Forrester, President and CEO of Verastem adds, “The Boston CEO Conference is a premier forum for the leaders in healthcare to come together. It is the attendees that drive the quality of this conference– the Boston CEO Conference gathers an outstanding group of executives in our space and the discussions and topics explored are an integral resource for successfully navigating the life science market.”

Conference speakers include: Mike Bonney (formerly of Cubist Pharmaceuticals), Michelle Dipp (OvaScience), Deborah Dunsire (FORUM Pharmaceuticals), Kurt Graves (Intarcia), Susan Hockfield (MIT), David Meeker (Genzyme), Flemming Ornskov (Shire) and Henri Termeer (Genzyme), among others.

For more information including full agenda and to register for the conference, please visit: http://bbbiotechconference.com/conference-agenda.php?id=33

ABOUT THE BOSTON BIOTECH CONFERENCES
The Boston Biotech Conferences (BBC)’s mission is to build a vibrant community of biopharma leaders, which will help to drive innovation in biotech, and bring important drugs to patients more quickly. The conferences are exclusive, thought-leader forums for senior biopharma executives. Each conference is highly interactive and co-hosted by healthcare industry leaders to foster discussions and facilitate information-sharing, networking and corporate development within the biopharma community. The meetings are invitation-only, off-the-record forums that bring together the past, present and future leaders in the healthcare community to network, exchange ideas and share insights into the industry's challenges and opportunities. For more information on BBC, please visit: http://www.bbbiotechconference.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Cristina Ojeda
@BiotechConf
Follow >
Boston Biotech Conferences
since: 05/2012
Like >
Visit website